MiNK Therapeutics Inc.
INKT | NASDAQ
$12.10
-$0.15 (-1.22%)
Sep 22, 2026, 12:20 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 118.28K | 167.05K | 181.75K | 197.05K | 216.03K | 212.37K | 215.44K | 215.14K | 205.96K | 212.76K | 204.62K | 188.98K | 163.96K | 140.36K | 121.75K | 107.65K | 99.51K | 71.2K | 60.31K | 36.48K | 16.19K | 16.19K |
Gross Profit | -118.28K | -167.05K | -181.75K | -197.05K | -216.03K | -212.37K | -215.44K | -215.14K | -205.96K | -212.76K | -204.62K | -188.98K | -163.96K | -140.36K | -121.75K | -107.65K | -99.51K | -71.2K | -60.31K | -36.48K | -16.19K | -16.19K |
Operating Income | -9.15M | -12.84M | -12.49M | -11.43M | -10.14M | -9.35M | -10.65M | -13.94M | -17.46M | -20.9M | -22.92M | -25.31M | -28.07M | -29.43M | -30.95M | -29.37M | -25.53M | -23.45M | -19.77M | -14.98M | -16.75M | -14.74M |
Interest Income | 66.97K | 67.32K | n/a | 108.59K | 131.45K | 169.47K | 172.57K | 174.52K | 203.79K | 311.82K | 463.26K | 556.57K | 542.24K | 422.23K | 254.17K | 119.34K | 26.38K | n/a | n/a | n/a | n/a | 557.55K |
Pretax Income | -3.14B | -12.47M | -12.49M | -12.36M | -11.28M | -9.74M | -10.79M | -13.78M | -17.09M | -20.59M | -22.46M | -24.77M | -25.98M | -25.9M | -27.99M | -25.99M | -33.92M | -34.14M | -30.21M | -25.98M | -17.76M | -15.75M |
Net Income | -3.14B | -12.47M | -12.49M | -12.36M | -11.28M | -9.74M | -10.79M | -13.78M | -17.09M | -20.59M | -22.46M | -24.77M | -25.98M | -25.9M | -27.99M | -25.99M | -33.92M | -34.14M | -30.21M | -25.98M | -17.76M | -15.75M |
Selling & General & Admin | 9.73B | 8.41B | 6.73B | 5.63M | 4.92M | 4.09M | 4.1M | 5.48M | 6.12M | 6.84M | 7.23M | 7.13M | 7.2M | 7.26M | 7.71M | 8.01M | 7M | 6.07M | 4.58M | 2.55M | 2.22M | 1.92M |
Research & Development | 8.85B | 6.96B | 5.76B | 5.65M | 5.05M | 5.05M | 6.34M | 8.24M | 11.13M | 13.85M | 15.49M | 17.99M | 20.71M | 22.03M | 23.12M | 21.25M | 18.44M | 16.15M | 13.97M | 10.8M | 9.97M | 9.5M |
Other Expenses | -15.35B | -15.35B | -12.47B | -48.76K | -48.76K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.16M | 1.16M | 1.59M | 4.54M | 3.3M |
Operating Expenses | 3.23B | 12.67M | 12.31M | 11.23M | 9.92M | 9.14M | 10.43M | 13.72M | 17.25M | 20.68M | 22.72M | 25.12M | 27.91M | 29.29M | 30.83M | 29.27M | 25.44M | 23.38M | 19.71M | 14.94M | 16.74M | 14.72M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 848 | 2.4K | 883.72K | 1.69M | 2.43M | 3.12M | 2.87M | 2.07M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 9.15M | 12.84M | 12.49M | 11.43M | 10.14M | 9.35M | 10.65M | 13.94M | 17.46M | 20.9M | 22.92M | 25.31M | 28.07M | 29.43M | 30.95M | 29.37M | 25.53M | 23.45M | 19.77M | 14.98M | 16.75M | 14.74M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 5.02M | 4.8M | 4.27M | 4.44M | 3.98M | 3.96M | 3.77M | 3.74M | 3.71M | 3.46M | 3.46M | 3.45M | 3.44M | 3.4M | 3.38M | 3.38M | 3.36M | 3.35M | 3.29M | 3.29M | 2.84M | 2.84M |
Shares Outstanding (Diluted) | 5.02M | 4.8M | 4.27M | 4.44M | 3.98M | 3.96M | 3.77M | 3.95M | 3.71M | 3.46M | 3.46M | 3.45M | 3.44M | 3.4M | 3.38M | 3.38M | 3.36M | 3.35M | 3.29M | 3.29M | 2.84M | 2.84M |
EPS (Basic) | -2.39 | -2.83 | -2.96 | -3.06 | -2.89 | -2.56 | -2.96 | -3.89 | -4.89 | -5.96 | -6.53 | -7.15 | -7.07 | -6.57 | -7.30 | -6.90 | -9.80 | -10.70 | -9.70 | -8.44 | -6.24 | -5.84 |
EPS (Diluted) | -2.39 | -2.83 | -2.96 | -3.06 | -2.87 | -2.54 | -2.94 | -3.87 | -4.89 | -5.96 | -6.53 | -7.15 | -7.07 | -6.57 | -7.30 | -6.90 | -9.80 | -10.70 | -9.70 | -8.44 | -6.24 | -5.84 |
EBITDA | -8.11M | -12.3M | -12.31M | -12.16M | -11.06M | -9.53M | -10.57M | -13.57M | -16.88M | -20.37M | -22.25M | -24.58M | -25.82M | -25.76M | -27.87M | -25.88M | -32.94M | -32.37M | -27.71M | -22.43M | -14.45M | -12.6M |
EBIT | -8.23M | -12.46M | -12.49M | -12.36M | -11.28M | -9.74M | -10.79M | -13.78M | -17.09M | -20.59M | -22.46M | -24.77M | -25.98M | -25.9M | -27.99M | -25.99M | -33.04M | -32.46M | -27.78M | -22.5M | -14.52M | -12.66M |
Depreciation & Amortization | 118.28K | 167.05K | 181.75K | 197.05K | 216.03K | 212.37K | 215.44K | 215.14K | 205.96K | 212.76K | 204.62K | 188.98K | 163.96K | 140.36K | 121.75K | 107.65K | 99.51K | 88.84K | 77.96K | 70.26K | 64.81K | 59.21K |
Add to Watchlist
Select watchlists to add or remove INKT